Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
108 Results for "
Hgf
" in MedChemExpress (MCE) Product Catalog:
Products (108)
108 Results for "Hgf" in MCE Product Catalog:
Cat. No.: HY-P86709A
Synonyms: Interleukin BSF 2; B cell differentiation factor; B cell stimulatory factor 2; BSF 2; BSF2; CDF; CTL differentiation factor; Cytotoxic T cell differentiation factor; Hepatocyte stimulating factor; Hgf; HPGF; HSF; Hybridoma growth factor; Hybridoma plasmacytoma growth factor; IFNB2; IL 6; IL6 protein; Interferon beta 2; Interleukin 6(interferon beta 2); Interleukin 6; Interleukin-6; Interleukin6; IL6_HUMAN.
Cat. No.: HY-P86709
Synonyms: Interleukin BSF 2; B cell differentiation factor; B cell stimulatory factor 2; BSF 2; BSF2; CDF; CTL differentiation factor; Cytotoxic T cell differentiation factor; Hepatocyte stimulating factor; Hgf; HPGF; HSF; Hybridoma growth factor; Hybridoma plasmacytoma growth factor; IFNB2; IL 6; IL6 protein; Interferon beta 2; Interleukin 6(interferon beta 2); Interleukin 6; Interleukin-6; Interleukin6; IL6_HUMAN.
Cat. No.: HY-P80803A
Synonyms: MET; Hepatocyte growth factor receptor; Hgf receptor; Hgf/SF receptor; Proto-oncogene c-Met; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met
Cat. No.: HY-P706296
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ¹⁵N-Recombinant Human IL-6; ¹⁵N-Recombinant Human Interleukin-6; ¹⁵N-Human IL-6 (Recombinant); ¹⁵N-Human Interleukin-6 (Recombinant); IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); Hgf; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, Beta 2; CTL Differentiation Factor; Interleukin BSF-2; Interleukin 6; Interferon Beta-2
Species:
Human
Source:
E. coli
Cat. No.: HY-P705989
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Hgf; Hepatocyte Growth Factor (Hepapoietin A; Scatter Factor); Prev. DFNB39; Lung Fibroblast-Derived Mitogen; HPTA; Hepatopoietin-A; SF; Scatter Factor; F-TCF; Deafness, Autosomal Recessive 39; HgfB; Hepatopoietin A; Hepatocyte Growth Factor; Fibroblast-D
Species:
Bovine
Source:
HEK293
Cat. No.: HY-106961R
CAS No.: 176391-41-6
Synonyms: ONO-AP 500-02 (Standard)
Research Areas:
ONO 1301 (Standard) (ONO-AP 500-02 (Standard)) is the analytical standard of ONO 1301 (HY-106961). This product is intended for research and analytical applications. ONO 1301 (ONO-AP 500-02), a prostaglandin (PG) I2 mimetic, is an orally active, long-acting prostacyclin agonist with thromboxane-synthase inhibitory activity. ONO 1301 promotes production of hepatocyte growth factor (HGF) from various cell types and ameliorates ischemia-induced left ventricle dysfunction in the mouse, rat and pig .
Cat. No.: HY-187892
CAS No.: 3060541-19-4
Synonyms: ATH-1105
Target:
Research Areas:
Brelgometon (ATH-1105) is an orally active HGF/MET positive modulator . Brelgometon activates downstream ERK and AKT cascades. Brelgometon reduces pro-inflammatory cytokine levels and extranuclear TDP-43 aggregation; it also upregulates EAAT2 expression and improves mitochondrial function. Brelgometon protects neurons from excitotoxicity, inflammation, oxidative stress and mitochondrial dysfunction; it also maintains neurite length, neuromuscular junction integrity and sciatic nerve function. Brelgometon alleviates motor function deterioration, maintains body weight and prolongs survival in ALS transgenic mice. Brelgometon is applicable to research related to amyotrophic lateral sclerosis .
Cat. No.: HY-E70750
Target:
Research Areas:
Mesenchymal-to-epithelial transition (MET) is a receptor tyrosine kinase for hepatocyte growth factor (HGF). MET overactivation is strongly associated with angiogenesis, cellular motility, growth, and invasion. Aberrant MET signaling can drive tumorigenesis in several cancer types through various molecular mechanisms, including MET amplification, MET exon 14 skipping mutation, MET overexpression, and MET fusions. MET F1200I is a mutant of MET. MET F1200I Recombinant Human Active Protein Kinase is a recombinant MET F1200I protein that can be used to study MET F1200I-related functions .
Cat. No.: HY-P70202
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SPINT2; Hepatocyte Growth Factor Activator Inhibitor-2; Serine Peptidase Inhibitor, Kunitz Type 2; Serine Protease Inhibitor, Kunitz Type, 2; HAI-2; Hgf Activator Inhibitor 2; HAI2; Placental Bikunin; Hepatocyte Growth Factor Activator Inhibitor Type 2; T
Species:
Human
Source:
HEK293
Cat. No.: HY-P76964
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SPINT2; Hepatocyte Growth Factor Activator Inhibitor-2; Serine Peptidase Inhibitor, Kunitz Type 2; Serine Protease Inhibitor, Kunitz Type, 2; HAI-2; Hgf Activator Inhibitor 2; HAI2; Placental Bikunin; Hepatocyte Growth Factor Activator Inhibitor Type 2; T
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P810465
Synonyms: REST, RE1 Silencing Transcription Factor, NRSF, XBR, RE1-Silencing Transcription Factor, Neural-Restrictive Silencer Factor, DFNA27, Neuron-Restrictive Silencer Factor, Neuron Restrictive Silencer Factor, Deafness, Autosomal Dominant 27, Repressor Binding To The X2 Box, X2 Box Repressor, GINGF5, Hgf5, WT6
Cat. No.: HY-12017C
CAS No.: 1159490-83-1
Target:
PF-04217903 phosphate is an orally active, highly selective ATP-competitive c-Met kinase inhibitor with a Ki value of 4.8 nM and a Kd value of 4.5 nM. PF-04217903 phosphate blocks c-Met and HGF signaling pathways, inhibits MET phosphorylation, and blocks downstream MAPK, PI3K/AKT and PLCγ1 pathways. PF-04217903 phosphate suppresses tumor proliferation, survival, migration, invasion, angiogenesis and metastasis, induces apoptosis, and enhances efferocytosis, Annexin A1 expression and resolution of inflammation. PF-04217903 phosphate retains activity against several c-Met mutants (M1131T, V1220I, H1094R). PF-04217903 phosphate increases the incidence of subarachnoid hemorrhage and reduces survival rate without altering aneurysm formation, and also prevents lymph node metastasis induced by VEGF inhibition. PF-04217903 phosphate is applicable to research related to tumors (pancreas, stomach, lung, brain, colon, breast, kidney, melanoma, etc.), intracranial aneurysms and inflammatory diseases (gouty arthritis, neutrophilic pleuritis) .
Cat. No.: HY-P73220
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); Hgf; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, Beta 2; CTL Differ
Species:
Pig
Source:
E. coli
Cat. No.: HY-P79088
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); Hgf; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, Beta 2; CTL Differ
Species:
Canine
Source:
E. coli
Cat. No.: HY-P79101
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); Hgf; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, Beta 2; CTL Differ
Species:
Equine
Source:
E. coli
Cat. No.: HY-P704193
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SOS1; Son Of Sevenless Homolog 1 (Drosophila), Isoform CRA_d; Prev. GINGF; Guanine Nucleotide Exchange Factor; Hgf; Uncharacterized Protein SOS1; GF1; Alternate SOS1; Gingival Fibromatosis, Hereditary, 1; GGF1; Son Of Sevenless Homolog 1; NS4; SOS-1; SOS
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P7044AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); Hgf; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, Beta 2; CTL Differ
Species:
Human
Source:
E. coli
Cat. No.: HY-P78853
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); Hgf; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, Beta 2; CTL Differ
Species:
Mouse
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
